Advanced Analytics Archives - Axtria - Ingenious Insights

Select Page

White Paper

Data-Driven Customer Journey Design Using Bayesian Network Methodology

Roundtable

Pharma Omnichannel Trends In A Post-COVID World

Report

HEOR Value Demonstration and Evidence Generation Challenges

White Paper

Do Pharma Companies Need To Rethink Their Sales Operations Design?

White Paper

What Analytical Techniques Should Pharma Companies Implement To Forecast COVID-19 Effects?

White Paper

Effects Of A Resurgence In COVID-19 Cases On Future Pharmaceutical Business Planning

White Paper

COVID-19 Recession Effects On Pharmaceutical-Related Patient Health Outcomes

White Paper

Coronavirus Pandemic Effects On Incentive Compensation

White Paper

Designing A Patient-Centric Commercial Strategy

White Paper

How Will The Coronavirus Pandemic Affect The US Pharmaceutical Industry?

White Paper

Can The Coronavirus Contagion Economically Infect The Global Pharmaceutical Industry?

White Paper

One Important Lesson From Biogen’s Surprise Announcement On Hopes For An Alzheimer’s Drug

White Paper

Importation Of Drugs Is Back Again On The Pharma Public Policy Table – A Short Commentary

White Paper

AstraZeneca’s Bold And Potentially Risky New Cancer Drug R&D Portfolio Strategy

White Paper

How Will The Next Great Recession Affect The US Pharma Industry?

White Paper

Future Of Pharma: Evolving Commercial Models – Part 2

White Paper

Do Pharma Mergers And Acquisitions Improve R&D Productivity And Increase Shareholder Value?

White Paper

Politics ‘Trumps’ Rational Policy Rule Change On Ending Rebates To PBMs For The Medicare Program

Report

Future Of Pharma: Evolving Commercial Models – Part 1

White Paper

Proposed Rule To End Rebates To PBMs For Medicare And Medicaid Programs

Report

How Regulatory Changes Are Driving The Future Of The Medical Device Industry

White Paper

Growing Attention Being Paid To Pharma Company Rebates And Discounts

White Paper

Perspectives On Pharma Company Use Of Open Payments Data

White Paper

Challenges And Opportunities To Commercialize Orphan Drugs For Rare Diseases In The US

WP-Life-Sciences--Consumer-Health-Cover

White Paper

The recent woes of non-bank mortgage servicers

WP-Maximizing-Marketing-ROI-Cover

White Paper

Account-based models in an institutional setting

WP-Impact-Of-COVID-19-Cover

White Paper

From “sick” care to “health” care: analytics-driven transformation

White Paper

Effective Quality Assurance For Banks

White Paper

Telematics – Watching Your Every Move

White Paper

Payer Influence On Product Performance In Pharmaceutical Industry

White Paper

Mortgage Servicer – You’ve Got Information!

White Paper

Operational Risk Computation Methodology

White Paper

Improve STAR Rating With Analytics Powered Therapy Adherence Strategy

White Paper

Is Channel ROI Dead?

Article

Risk Basel Methodology Implementation

White Paper

Linking Customer Focus With Business Performance

White Paper

Enabling Smarter Commercial Model Experimentation

Article

Claim Operations Optimization

White Paper

Portfolio Stress Testing Methodologies

White Paper

Evolution Of SDLC

White Paper

Behavioural Segment Based Stress Testing Using Markov Chain

White Paper

Borrower Centrism – Bring ‘Service’ Back Into Mortgage Servicing

White Paper

Basel Downturn – Identification & Estimation

White Paper

Operational Risk Management In Banks

White Paper

A Mathematical Framework For Privacy Risk

White Paper

Deploying K-Nearest Neighbor Modeling Methodologies For Real World Problems

White Paper

At Supplier Management Crossroads? – Choose The Right Approach

White Paper

Driver Score – The New Paradigm

White Paper

The Pricing Challenge Of Pharma’s Shift To Specialty Medicines

White Paper

Measuring Sales Rep-Physician Relationship Disruption In Sales Force Optimization & Territory Alignment

White Paper

Biosimilars In The US – Will They Deliver On The Promise?

Article

Impact Of State Pharmacy Drug Product Selection Laws On Patient Brand – Generic Drug Utilization

Article

Latest Pharma R&D Cost Estimates – Implications For The Expanded Use Of Commercial Analytics

White Paper

The Changing Role Of Pharma Sales And Marketing In A Specialty Medicine Environment

White Paper

The Relationship Between Drug Price Controls And Patient Health Outcomes

White Paper

Patient Claims Versus EHR Data – How To Choose Between The Two?

White Paper

Pharma Sales And Marketing Restrictions – Has the Pendulum Swung Too Far?

White Paper

Econometric Analysis Of Biopharmaceutical Transfer Pricing

Blog

Implications From HEOR And RWE Models For Biopharmaceutical Commercial Analytics

White Paper

Global Pharma Pricing and Market Effects of President Trump’s Proposed Policies

White Paper

Is it Time to Adjust the Pharma PDE Sales Force Optimization Model?

Report

State Of Commercial Excellence 2017 – Part 1

Article

Sales Analytics and Big Data Developments Needed Now to Address Sales Force Issues

White Paper

Pricing and Market Effects of Biosimilar Entry in the US

White Paper

The Reasons for and Solutions to Chronic Drug Shortages in the United States

White Paper

Decision Science Asset Diversification Versus Concentration

White Paper

Regional Sales And Marketing Optimization Modeling: A Call For Technical Changes

White Paper

Are Pharmaceutical Direct-To-Consumer TV Ads Appropriate? A Commentary

White Paper

The Causes and Solutions of Chronic Drug Shortages in the United States

White Paper

Insightful HEOR Analysis For The Cardiovascular Community

Blog

Quantifying The Economic Burden Of Inadequate Symptom Control Among Patients With IBS-D

White Paper

Quantifying The Economic Burden Of IBS-D